Global Health Statistics 2025: SDG Progress Report

Global Life Expectancy Trends 2000-2025

The WHO World Health Statistics 2025 report reveals remarkable global health progress followed by unprecedented setbacks. Between 2000 and 2019, global life expectancy at birth increased by an impressive 6.3 years, rising from 66.8 to 73.1 years. This represents one of the most significant periods of health improvement in human history.

Healthy life expectancy (HALE) – the number of years a person can expect to live in good health – showed equally impressive gains, increasing by 5.4 years from 58.1 to 63.5 years during the same period. These improvements were driven primarily by reductions in communicable diseases, perinatal conditions, and nutritional deficiencies, which contributed approximately 3.4 years to the HALE gains.

However, the COVID-19 pandemic dramatically altered this trajectory. Between 2019 and 2021, global life expectancy dropped by 1.8 years, erasing nearly a decade of progress in just two years. This represents the largest decline in life expectancy since World War II, highlighting the pandemic’s devastating global impact on population health.

The global health monitoring systems tracked these changes in real-time, providing unprecedented visibility into worldwide health trends and enabling rapid policy responses.

COVID-19 Impact on Global Health

The pandemic’s impact on global health extends far beyond direct COVID-19 deaths. The WHO analysis reveals that COVID-19 and pandemic-related outcomes accounted for approximately 1.57 years of HALE loss between 2019 and 2021. Direct COVID-19 deaths contributed 1.29 years of this loss, while other pandemic-related outcomes – including delayed healthcare, economic disruption, and social isolation – added another 0.28 years.

Mental health emerged as a significant casualty of the pandemic. Anxiety and depressive disorders each contributed approximately 0.06 years of HALE loss, together erasing nearly 80% of the non-communicable disease (NCD) mortality gains achieved between 2019 and 2021. This mental health crisis particularly affected younger populations, creating long-term implications for global health systems.

The pandemic also revealed stark global inequalities in health system resilience. High-income countries with robust healthcare infrastructure generally managed better outcomes, while low- and middle-income countries faced cascading health system failures that extended far beyond COVID-19 treatment capacity.

Major Disease and Mortality Drivers

The WHO report identifies specific diseases and conditions that have driven global health improvements and setbacks. Lower respiratory infections led the gains, contributing 0.40 years to HALE improvements between 2000-2019, followed closely by reductions in diarrheal diseases (+0.35 years), stroke (+0.37 years), and ischemic heart disease (+0.28 years).

Infectious disease control showed remarkable success. Tuberculosis reductions contributed 0.27 years to HALE gains, while HIV/AIDS control added 0.22 years – testament to global investment in infectious disease programs and prevention strategies. These achievements demonstrate the effectiveness of coordinated international health interventions.

However, non-communicable diseases present growing challenges. Diabetes morbidity increased significantly, costing approximately 0.14 years of HALE between 2000-2019. This trend reflects changing lifestyle patterns, urbanization, and dietary transitions affecting populations worldwide, particularly in middle-income countries undergoing rapid economic development.

Regional Health Disparities

WHO regional analysis reveals persistent and concerning health inequalities. The African Region demonstrated significant progress in reducing HIV-related mortality and child infectious diseases, but continues to face challenges with maternal mortality and healthcare access. Gains in life expectancy in Africa were substantial, yet the region still lags behind global averages.

The Americas Region showed mixed results, with significant progress in cardiovascular disease mortality offset by rising concerns about drug use disorders and violence-related deaths. The region’s health systems demonstrated resilience during COVID-19 but revealed underlying inequalities between and within countries.

Europe faced unique challenges with rising dementia prevalence as populations age, while achieving continued reductions in ischemic heart disease and stroke mortality. The region’s experience highlights the “success penalty” of improved longevity – living longer but facing age-related conditions that require intensive healthcare resources.

The Eastern Mediterranean Region confronted diabetes morbidity increases and violence-related health impacts, while the Southeast Asia and Western Pacific Regions showed varying patterns based on economic development levels and health system maturity. These regional health disparities underscore the need for context-specific interventions.

SDG Health Indicators Progress

Progress toward health-related Sustainable Development Goals shows a mixed picture as the 2030 deadline approaches. Maternal mortality rates fell by approximately one-third between 2000-2019, representing significant progress but still insufficient to meet 2030 targets. Many countries, particularly in sub-Saharan Africa, require accelerated intervention to achieve SDG 3.1 targets.

Child mortality achievements were more encouraging, with rates declining by more than half during the 2000-2019 period. However, progress has slowed in recent years, and the COVID-19 pandemic disrupted routine childhood immunizations and healthcare services, threatening to reverse gains in child survival.

Premature mortality from non-communicable diseases presents ongoing challenges. While absolute numbers have improved in many regions, the rate of decline remains insufficient to meet the SDG target of reducing premature NCD mortality by one-third by 2030. Cancer, cardiovascular disease, diabetes, and chronic respiratory diseases continue to be leading causes of premature death globally.

Environmental health targets show concerning trends. Air pollution remains a major mortality driver, particularly in rapidly industrializing regions. Access to safely managed drinking water and sanitation has improved but remains inadequate in many areas, with rural populations disproportionately affected by these basic health determinants.

Infectious Disease Trends

The global infectious disease landscape shows both victories and emerging challenges. HIV incidence continued its downward trend, with new infections declining significantly since peak levels. TB incidence also decreased, though progress has been slower than needed to achieve elimination targets. These successes reflect sustained investment in prevention, treatment, and care programs.

However, malaria presents a concerning reversal. After years of decline, malaria incidence has increased since 2015, particularly in high-burden African countries. Climate change, insecticide resistance, and healthcare system disruptions have contributed to this setback, threatening decades of progress in malaria control.

Hepatitis B remains a significant global health challenge, with mother-to-child transmission continuing despite available prevention strategies. The WHO targets for hepatitis elimination require accelerated action in vaccination coverage and treatment access, particularly in endemic regions.

Antimicrobial resistance (AMR) emerges as an increasingly critical threat. The WHO report highlights growing resistance patterns across major bacterial pathogens, threatening the effectiveness of common antibiotics and potentially reversing advances in medical care. WHO’s AMR surveillance data shows concerning trends that require immediate global action.

Risk Factors and Environmental Health

Global risk factor trends present a mixed landscape of progress and persistent challenges. Tobacco use continues its global decline, but the rate of reduction remains insufficient to meet WHO Framework Convention targets. While high-income countries have achieved substantial reductions, tobacco use persists in many low- and middle-income countries, often targeting vulnerable populations.

Alcohol consumption shows regional variations, with the world on track to achieve a 20% reduction in per capita consumption by 2030 at the global level. However, this aggregate progress masks concerning increases in several regions, particularly among women and young people in some countries.

Air pollution remains one of the world’s leading environmental health risks. WHO air quality data shows that 99% of the global population lives in areas exceeding WHO air quality guidelines. Fine particulate matter (PM2.5) and ozone pollution contribute significantly to cardiovascular disease, stroke, lung cancer, and chronic respiratory diseases.

Malnutrition presents a complex global picture. While severe acute malnutrition has declined, overweight and obesity rates continue rising globally, creating a double burden of malnutrition in many countries. Stunting in children under five has decreased but remains unacceptably high in several regions, affecting long-term cognitive and physical development.

Violence against women and girls remains a persistent global health issue. The WHO report documents continued high prevalence rates across all regions, with intimate partner violence affecting approximately one in four women globally. This represents not only a human rights crisis but also a significant public health challenge requiring comprehensive societal responses.

Universal Health Coverage Data

Universal Health Coverage (UHC) progress reveals significant challenges in achieving the SDG target of ensuring all people have access to essential health services without financial hardship. The WHO Service Coverage Index shows gradual improvements globally, but progress varies dramatically between regions and income levels.

Financial protection remains elusive for millions. In 2019, approximately 344 million people were pushed into or further into extreme poverty by out-of-pocket health payments. This represents a slight improvement from previous years but highlights the persistent challenge of healthcare affordability in many health systems.

Catastrophic health expenditures affect 13.5% of the global population, who spend more than 10% of their household budget on healthcare. This burden falls disproportionately on low-income households and those in countries with limited social protection systems, creating cycles of poverty and poor health outcomes.

The WHO Triple Billion targets for UHC show concerning shortfalls. By 2024, only 431 million additional people gained access to essential health services, far short of the 1 billion target. Projections suggest approximately 500 million by 2025, representing roughly a 50% shortfall from the ambitious goal set in 2019.

Health financing systems require fundamental reforms to achieve UHC. The report emphasizes the need for increased public health spending, improved efficiency in resource allocation, and stronger financial protection mechanisms. Healthcare financing innovation offers potential pathways to overcome these persistent challenges.

Health Workforce Crisis

The global health workforce shortage remains a critical constraint on health system performance and UHC achievement. WHO data shows the shortage decreased slightly from 15.4 million in 2020 to 14.7 million in 2023, but projections indicate an 11.1 million shortage by 2030 if current trends continue.

Regional distribution of health worker shortages shows stark inequalities. The African and Eastern Mediterranean Regions are projected to account for approximately 70% of unmet health workforce needs by 2030. This concentration of shortages in regions with the highest disease burdens creates significant barriers to health improvement and equity.

The COVID-19 pandemic highlighted both the critical importance of health workers and their vulnerability to occupational hazards. Healthcare worker infections, deaths, and burnout during the pandemic have intensified existing workforce challenges and complicated recruitment and retention efforts globally.

Health worker migration patterns exacerbate global inequalities. Many low-income countries train health professionals who subsequently migrate to higher-income countries, creating a brain drain that further weakens already strained health systems. WHO health workforce data documents these complex migration patterns and their health system impacts.

Triple Billion Targets Assessment

The WHO General Programme of Work 13th (GPW13) Triple Billion targets provide ambitious benchmarks for global health improvement. The “healthier lives” target achieved remarkable success, with approximately 1.35 billion more people living healthier lives by end-2024, exceeding the 1 billion target and projected to reach 1.5 billion by 2025.

However, the universal health coverage target faces significant challenges. With 431 million people gaining access to essential services by 2024, projections suggest approximately 500 million by 2025 – representing roughly a 50% shortfall from the 1 billion target. This gap highlights the complexity of health system strengthening and the need for sustained political commitment.

Health emergency protection showed mixed progress, with 637 million people better protected by 2024 and expectations of 697 million by 2025. While representing substantial progress, this falls approximately 30% short of the 1 billion target, reflecting ongoing vulnerabilities in global health security and emergency preparedness.

The transition from GPW13 to GPW14 presents opportunities to learn from these experiences and refine targets and strategies. The mixed success of Triple Billion targets provides valuable insights for setting realistic yet ambitious goals that can drive meaningful health improvements while acknowledging systemic constraints and challenges.

Immunization Equity Challenges

Immunization coverage reveals persistent within-country inequalities that threaten global health security and child survival. The WHO analysis of DTP3 (diphtheria-tetanus-pertussis third dose) coverage and zero-dose children – those who have not received any routine vaccines – shows concerning disparities by socioeconomic status, maternal education, and geographic location.

Positive trends emerge from recent data showing reduced economic-related inequality in low-income and lower-middle-income countries over the past decade. Economic inequality in DTP3 coverage and zero-dose prevalence has decreased by more than 50% across low-income countries, suggesting that targeted interventions can effectively address immunization inequities.

The potential impact of closing immunization gaps is substantial. WHO modeling suggests that eliminating inequalities across 88 low- and middle-income countries could raise national DTP3 coverage averages by approximately 10 percentage points and halve zero-dose child prevalence. This would significantly improve child survival and population immunity against vaccine-preventable diseases.

However, data availability remains a critical challenge for monitoring immunization equity. Many countries lack sufficient data disaggregation to identify and address inequalities effectively. WHO immunization monitoring systems are working to strengthen data collection and analysis capabilities to support equity-focused interventions.

The COVID-19 pandemic disrupted routine immunization services globally, threatening to reverse progress in childhood vaccine coverage. Recovery efforts must prioritize equity to ensure that the most vulnerable populations receive catch-up vaccination services and that immunization systems emerge stronger and more resilient from the pandemic experience.